A phase I clinical trial of cancer vaccine using multiple antigen epitope peptides for advanced cervical cancer

A phase I clinical trial of cancer vaccine using multiple antigen epitope peptides for advanced cervical cancer - Cancer vaccine using multiple antigen peptides for advanced cervical cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003999

Enrollment

Registered

2010-08-04

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced and recurrent cervical cancer

Interventions

vaccine with multiple antigen epitope peptides

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: HLA-A2402

Exclusion criteria

Exclusion criteria: severe heart disease patients treated with systemic corticosteroids

Design outcomes

Primary

Measure	Time frame
safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026